Asuragen, Inc., an oncology molecular diagnostic company and molecular biology service provider, was selected to provide GLP compliant laboratory testing to assist in gene expression studies being conducted by Millennium Pharmaceuticals of Cambridge, MA.

"We are committed to applying our RNA expertise to produce the data quality required in clinical studies with organizations such as Millennium and believe that research like this may enable companion diagnostics and support the value of personalized medicine," commented Scott Hunicke-Smith, vice president and general manager of Asuragen Services.

News from our sister sites